ADS Biosystems Inc. has a very experienced and highly skilled team. We have collaborated with repeat customers, such as Celgene, Genentech, Johnson and Johnson, Sanofi Europe, Science Exchange, UC Davis, UCSD, Intercept, and Third Rock Ventures, just to name a few. Our featured services include, but are not limited to, antigen-based affinity antibody purification, in vitro kinase assays, Alpha Screen, and custom ELISA kit development and testing. We specialize in cell-based assays, such as human M1 macrophage Caspase 1 activation, and many other luciferase-based assays in cells, like FXR based luciferase assays in cells. Our expertise is in human CD34+ hematopoietic stem cells and differentiation into human T cells. We are also conducting cell-based assays, such as luciferase assays, in a variety of primary cells, cell lines and tissue cultures. We provide molecular biology services, such as real time RT-PCR, quantitative Western Blot and ELISA. We have tested drug candidates for customers in a variety of cell-based models, hearing loss studies in our chemically deafened cochlear cultures, and for obesity and diabetes in vitro with adipocytes and in vivo with mouse models.
ADS Biosystems Inc. was founded in November 2013.